{"public_id":"co_b765e745a10a3f18e5fb923b0aac5586","status":"active","merged_into_public_id":null,"resolved_public_id":"co_b765e745a10a3f18e5fb923b0aac5586","name":"off-target affinities","description":"Binding strengths of drugs for unintended protein targets.","aliases":["affinities"],"types":["measurement"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":767946,"title":"Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets","citation_count":802,"url":"https://sah.borca.ai/papers/767946"}],"claims":[{"public_id":"cl_10791a4fb6982f4be8cee6aed208037a","text":"The newly confirmed off-target affinities ranged from 1 nM to 30 μM.","corpus_id":767946,"url":"https://sah.borca.ai/claims/cl_10791a4fb6982f4be8cee6aed208037a"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_b765e745a10a3f18e5fb923b0aac5586","url":"https://sah.borca.ai/concepts/co_b765e745a10a3f18e5fb923b0aac5586"}